Objective To obtain large scale and generalisable data on the long term predictive value of
cytology and human papillomavirus (HPV) testing for development of cervical intraepithelial …

Objectives To provide an early risk assessment of extending screening intervals beyond five
years for a human papillomavirus (HPV) based cervical screening programme in the …

Objective To compare the detection rates of precancerous and cancerous cervical lesions by
human papillomavirus (HPV) DNA testing and by conventional cytology screening. Design …

Objective To provide the first report on the main outcomes from the prevalence and
incidence rounds of a large pilot of routine primary high risk human papillomavirus (hrHPV) …

Objectives To assess whether the increased sensitivity of screening for human
papillomavirus (HPV) may represent overdiagnosis and to compare the long term duration of …

Background Screening for cervical cancer based on testing for human papillomavirus (HPV)
increases the sensitivity of detection of high-grade (grade 2 or 3) cervical intraepithelial …

Background Tests for the DNA of high-risk types of human papillomavirus (HPV) have a
higher sensitivity for cervical intraepithelial neoplasia grade 3 or worse (CIN3+) than does …

Objective To assess the performance and impact of primary human papillomavirus (HPV)
DNA screening with cytology triage compared with conventional cytology on cervical cancer …

The Canadian Cervical Cancer Screening Trial was a randomized controlled trial comparing
the performance of human papillomavirus (HPV) testing and Papanicolaou cytology to …

Objective Previous findings from cross-sectional studies have shown human papillomavirus
(HPV) testing to be more sensitive than cytology testing for primary cervical screening. This …